Showing results (201-210 of 242) with videos related to
Sort By:
Pageof 25
Molecular Cancer Therapeutics|December 7, 2002
Inhibition of Kirsten-ras expression in human colorectal cancer using rationally selected Kirsten-ras antisense oligonucleotidesP J Ross, M George, D Cunningham, et al.Analytical Biochemistry|October 25, 2001
High-throughput screening for identification of small molecule inhibitors of histone acetyltransferases using scintillating microplates (FlashPlate)F Turlais, A Hardcastle, M Rowlands, et al.Biochemical Pharmacology|July 13, 2001
Involvement of NADPH: cytochrome P450 reductase in the activation of indoloquinone EO9 to free radical and DNA damaging speciesS M Bailey, A D Lewis, L H Patterson, et al.Oncogene|August 30, 2000
Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperoneP A Clarke, I Hostein, U Banerji, et al.Anti-Cancer Drugs|June 1, 1994
Cyclopropamitosenes: novel bioreductive anticancer agents--mechanism of action and enzymic reductionC J Moody, N O'Sullivan, I J Stratford, et al.International Journal of Cancer|October 1, 1994
Differential intracellular processing of the anthracycline drug ME2303 in doxorubicin-sensitive (A2780) and -resistant (A2780AD) human ovarian cancer cells as studied with confocal laser scanning microscopy and image analysisI M Huxham, A L Barlow, A D Lewis, et al.British Journal of Cancer|January 1, 1997
Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9S M Bailey, M D Wyatt, F Friedlos, et al.Anti-Cancer Drug Design|April 1, 1996
The pharmacokinetics, bioavailability and biodistribution in mice of a rationally designed 2-nitroimidazole hypoxia probe SR-4554E O Aboagye, A D Lewis, M A Graham, et al.Oncogene|December 3, 2013
Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteinsJ R Smith, E de Billy, S Hobbs, et al.British Journal of Cancer|February 12, 1998
The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554E O Aboagye, R J Maxwell, M R Horsman, et al.Pageof 25